Pharmaceutical Technology1 小时
Amesanar by RHEACELL for Diabetic Foot Ulcers: Likelihood of Approval
Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...
Future Market Insights11 天
Global Venous Ulcer Treatment Market Value to reach USD 7.61 Billion by 2033, expanding at ...
The global venous ulcer treatment market, valued at USD 2.96 billion in 2023, is projected to experience robust growth, with ...
Scientists Discover Potential Baldness Treatment During Wound Healing Research
Researchers from the University of Sheffield and COMSATS University in Pakistan have discovered a potential new treatment for ...
Taiwan News12 天
U.S. Advanced Wound Care Market Opportunities Exploring Emerging Trends and Markets
The U.S. Advanced Wound Care market has demonstrated strong growth, with its valuation at $3.35 billion in 2019, and projections suggest it will reach $4.97 billion by 2027. This ...
Pharmabiz3 天
US FDA approves AVITA Medical’s RECELL GO mini disposable cartridge to treat smaller wounds
US FDA approves AVITA Medical’s RECELL GO mini disposable cartridge to treat smaller wounds: Valencia, California Friday, December 27, 2024, 18:00 Hrs [IST] AVITA Medical, Inc., ...
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns, full-thickness skin defects, and vitiligo. The RECELL System, excluding ...